investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
MOLECULAR MECHANISMS BY WHICH IRF-8 REGULATES MYELOPOIESIS
Amy M Becker
0 Collaborator(s)
Funding source
National Institutes of Health (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
No posts
Related projects
Kenneth Lynn Wright
Natural Killer Cell Regulation by PRDM1 and IRF4/8
Leukaemia
Gerd P Pfeifer
5-hydroxymethylcytosine in Human Cancer
Leukaemia
Elizaveta V Benevolenskaya
RBP2 Regulation Through Differential Recruitment to Genomic Loci
Leukaemia
Pathology
Hematology and hematologic malignancies
Ulrich G. Steidl
Role of a Novel Homeobox Transcription Factor (HLX) in Acute Myeloid Leukemia
Leukaemia
Mitch Mcvey
Mechanisms and consequences of inaccurate DNA double-strand break repair
Leukaemia
Pathology
Michael Kharas
Characterizing MSI2 in leukemia
Leukaemia
Margaret A Goodell
Regulation of Hematopoietic Progenitors by de novo DNA Methylation
Leukaemia
Richard A Flavell
Understanding Hemotopoietic Neoplasias using Humanized Mice
Leukaemia
Pathology
Hematology and hematologic malignancies
Wenwei Hu
The Role of LIF, a Novel Negative Regulator of p53, in Colorectal Cancer
Leukaemia
